Literature DB >> 22509506

Stem cells: Don't believe the hype.

Michael Eisenstein.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22509506     DOI： 10.1038/nature11107

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Stem cell transplantation in multiple sclerosis: current status and future prospects.

Authors:  Gianvito Martino; Robin J M Franklin; Anne Baron Van Evercooren; Douglas A Kerr
Journal:  Nat Rev Neurol       Date:  2010-04-20       Impact factor: 42.937

Review 2.  Autologous haematopoietic stem-cell transplantation in multiple sclerosis.

Authors:  Gianluigi Mancardi; Riccardo Saccardi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

3.  The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

Authors:  Mark S Freedman; Amit Bar-Or; Harold L Atkins; Dimitrios Karussis; Francesco Frassoni; Hillard Lazarus; Neil Scolding; Shimon Slavin; Katarina Le Blanc; Antonio Uccelli
Journal:  Mult Scler       Date:  2010-01-19       Impact factor: 6.312

4.  Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.

Authors:  Richard K Burt; Yvonne Loh; Bruce Cohen; Dusan Stefoski; Dusan Stefosky; Roumen Balabanov; George Katsamakis; Yu Oyama; Eric J Russell; Jessica Stern; Paolo Muraro; John Rose; Alessandro Testori; Jurate Bucha; Borko Jovanovic; Francesca Milanetti; Jan Storek; Julio C Voltarelli; William H Burns
Journal:  Lancet Neurol       Date:  2009-01-29       Impact factor: 44.182

5.  Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

Authors:  Lianhua Bai; Donald P Lennon; Valerie Eaton; Kari Maier; Arnold I Caplan; Stephen D Miller; Robert H Miller
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

6.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.

Authors:  Peter Connick; Madhan Kolappan; Charles Crawley; Daniel J Webber; Rickie Patani; Andrew W Michell; Ming-Qing Du; Shi-Lu Luan; Daniel R Altmann; Alan J Thompson; Alastair Compston; Michael A Scott; David H Miller; Siddharthan Chandran
Journal:  Lancet Neurol       Date:  2012-01-10       Impact factor: 44.182

7.  Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors:  Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069
  7 in total
  1 in total

1.  Altered protein secretions during interactions between adipose tissue- or bone marrow-derived stromal cells and inflammatory cells.

Authors:  Hidemi Hattori; Masayuki Ishihara
Journal:  Stem Cell Res Ther       Date:  2015-04-16       Impact factor: 6.832
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.